Technical Analysis for MTEM - Molecular Templates, Inc.

Grade Last Price % Change Price Change
grade C 6.27 9.81% 0.56
MTEM closed up 9.81 percent on Friday, September 13, 2019, on 2.87 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MTEM trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%

Older signals for MTEM ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is headquartered in Austin, Texas.
Chemistry Cancer Treatment Of Cancer Oncology Solid Tumors Chemical Elements Cancer Treatments Lymphoma Serious Diseases Oxygen Prodrugs Evofosfamide Nitrogen Mustards
Is MTEM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.77
52 Week Low 3.19
Average Volume 89,440
200-Day Moving Average 5.8935
50-Day Moving Average 6.0254
20-Day Moving Average 5.2035
10-Day Moving Average 5.383
Average True Range 0.3877
ADX 28.09
+DI 29.5691
-DI 16.2427
Chandelier Exit (Long, 3 ATRs ) 5.2769
Chandelier Exit (Short, 3 ATRs ) 5.6731
Upper Bollinger Band 5.8812
Lower Bollinger Band 4.5258
Percent B (%b) 1.29
BandWidth 26.047852
MACD Line -0.0286
MACD Signal Line -0.2196
MACD Histogram 0.191
Fundamentals Value
Market Cap 168.54 Million
Num Shares 26.9 Million
EPS -41.61
Price-to-Earnings (P/E) Ratio -0.15
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.61
Resistance 3 (R3) 7.52 6.98 7.39
Resistance 2 (R2) 6.98 6.64 7.03 7.31
Resistance 1 (R1) 6.63 6.43 6.80 6.72 7.24
Pivot Point 6.09 6.09 6.17 6.13 6.09
Support 1 (S1) 5.73 5.74 5.91 5.82 5.30
Support 2 (S2) 5.19 5.53 5.24 5.23
Support 3 (S3) 4.84 5.19 5.15
Support 4 (S4) 4.93